As the popularity of cannabidiol (CBD) increases, more patients are interested in trying a natural adjunct to more standard medications. But with no current FDA oversight, an estimated 70% of CBD products could be mislabeled. In Vermont, federal regulation requires hemp products to contain less than 0.3% THC, but this has only been tested one time at one location since the 2018 Farm Bill was passed. The goal of this project was to address common questions, recommend specific dosing, identify what to look for when purchasing, and list local and online resources for patients about CBD. An educational handout and a smartphrase were created to address these concerns.https://scholarworks.uvm.edu/fmclerk/1567/thumbnail.jp
